You searched for lawsuit - Page 4 of 22

Liveyon leader John Kosolcharoen pleads to federal felony charges on stem cells

August 27, 2024 / Professor Paul Knoepfler, Ph.D. / 2 Comments

The stem cell clinic arena is a Wild West but perhaps few have been wilder than the perinatal stem cell clinic firm Liveyon run by John Kosolcharoen. Now John Kosolcharoen has pleaded guilty to felony charges related to Liveyon’s activities including distribution of an unapproved cell therapy drug. He will be sentenced next month. This […]

Liveyon leader John Kosolcharoen pleads to federal felony charges on stem cells Read More »

Weekly stem cell reads: AI-human hybrids, eye drops, Cell Surgical Network case delay

August 18, 2024 / Professor Paul Knoepfler, Ph.D. / Leave a Comment

Before we jump into our weekly stem cell and regenerative medicine reads, check out my new video on our stem cell YouTube channel below on robots with human brain tissue. In that video, I discuss the integration of computers and other technologies into the human body. When involving the brain, these technologies are often called

Weekly stem cell reads: AI-human hybrids, eye drops, Cell Surgical Network case delay Read More »

Lung Institute stem cell clinic loses class action suit, patients awarded $9M

July 2, 2024 / Professor Paul Knoepfler, Ph.D. / Leave a Comment

Remember the Lung Institute? Many patients raised red flags about their experiences there. It was also once known as the Lung Health Institute. More generally, patients who have been harmed by stem cell clinics have had to rely on other ways beyond the FDA to try to do something about it. The FDA has been

Lung Institute stem cell clinic loses class action suit, patients awarded $9M Read More »

Recent stem cell & regenerative medicine good news

April 30, 2024 / Professor Paul Knoepfler, Ph.D. / 3 Comments

Looking for some stem cell good news? You’ll like today’s post. One mission of this blog The Niche is to promote rigorous science-based regenerative medicine, which can lead to investigating and writing about not-so-upbeat stuff. Risky clinics. People getting hurt. Patient lawsuits. Serious FDA, FTC, or state AG regulatory developments. Such actions can be good

Recent stem cell & regenerative medicine good news Read More »

Georgia AG & FTC win Superior Healthcare stem cell clinic case, seek $17 million

March 27, 2024 / Professor Paul Knoepfler, Ph.D. / 3 Comments

STEVEN D. PEYROUX, Georgia stem cell clinic

An unproven Georgia stem cell clinic called Superior Healthcare and other co-defendants recently lost a key court case. Some of you may remember that the Attorney General (AG) of Georgia Chris Carr and the FTC have been collaborating on this case. Now we have the good news that they have won the case via a

Georgia AG & FTC win Superior Healthcare stem cell clinic case, seek $17 million Read More »

9th Circuit hearing on FDA appeal of Cell Surgical Network case: maybe encouraging?

February 7, 2024 / Professor Paul Knoepfler, Ph.D. / 5 Comments

I was able to watch some of the 9th Circuit Court hearing today on the FDA appeal of its loss in the Cell Surgical Network lawsuit. This post is my brief impressions as a scientist. What went down? Do the three judges seem to be leaning one way or another? The ruling in this case

9th Circuit hearing on FDA appeal of Cell Surgical Network case: maybe encouraging? Read More »

Weekly reads: Xist & autoimmune disease in women, Crohn’s disease, dumb headline of the week

February 4, 2024 / Professor Paul Knoepfler, Ph.D. / Leave a Comment

Readers of The Niche have asked me many questions about stem cells for autoimmune disease but the puzzle of why women get these conditions more often than men hasn’t come up before here. For instance, why is MS so much more common in women than men? It’s remained somewhat of a mystery over the years.

Weekly reads: Xist & autoimmune disease in women, Crohn’s disease, dumb headline of the week Read More »

Weekly reads: MiMedX & Kimera Labs FDA warnings, NYT on Bryan Johnson, MUSE cell trial

January 21, 2024 / Professor Paul Knoepfler, Ph.D. / 10 Comments

Placental biologics firm MiMedx and exosome company Kimera Labs both recently received FDA warning letters. The letter to MiMedx was related to its placental biologics products and procedures. The new warning to Kimera Labs was about its exosome products and an amniotic product. Let’s compare these letters starting with the one to MiMedX. MiMedx warning letter

Weekly reads: MiMedX & Kimera Labs FDA warnings, NYT on Bryan Johnson, MUSE cell trial Read More »

Search Results for: lawsuit